Chemed Corporation (NYSE:CHE) Given Average Recommendation of “Hold” by Analysts

Shares of Chemed Corporation (NYSE:CHE) have been assigned an average rating of “Hold” from the six research firms that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $498.00.

Several analysts recently issued reports on CHE shares. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $422.00 price target (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Oppenheimer decreased their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Zacks Research lowered Chemed from a “hold” rating to a “strong sell” rating in a research note on Wednesday, March 4th. Finally, Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total value of $806,360.00. Following the completion of the transaction, the chief executive officer directly owned 93,719 shares in the company, valued at approximately $37,785,626.42. This represents a 2.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 3.29% of the company’s stock.

Institutional Investors Weigh In On Chemed

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CHE. Monetary Solutions Ltd acquired a new stake in shares of Chemed during the fourth quarter valued at about $25,000. Los Angeles Capital Management LLC acquired a new position in shares of Chemed in the fourth quarter worth about $26,000. Smartleaf Asset Management LLC lifted its stake in shares of Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after acquiring an additional 25 shares in the last quarter. BOK Financial Private Wealth Inc. purchased a new position in Chemed in the fourth quarter valued at about $27,000. Finally, First Horizon Corp acquired a new stake in Chemed during the 3rd quarter valued at approximately $31,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Price Performance

Chemed stock opened at $371.46 on Friday. The company has a market cap of $5.11 billion, a price-to-earnings ratio of 20.22, a price-to-earnings-growth ratio of 1.48 and a beta of 0.46. Chemed has a 12 month low of $368.44 and a 12 month high of $623.60. The stock’s 50-day moving average is $429.83 and its 200-day moving average is $436.19.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a net margin of 10.48% and a return on equity of 25.66%. The business had revenue of $639.34 million during the quarter, compared to analysts’ expectations of $659.09 million. During the same quarter in the previous year, the business posted $6.83 EPS. The company’s quarterly revenue was down .1% on a year-over-year basis. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Research analysts anticipate that Chemed will post 21.43 EPS for the current year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were paid a dividend of $0.60 per share. The ex-dividend date was Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. Chemed’s dividend payout ratio (DPR) is currently 13.06%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.